有接近丸美生物的人士告诉经济观察报，缺少对高管的激励措 施或为管理层流动的原因之一。 作者：罗文利 封图：图虫创意 广东丸美生物技术股份有限公司（下称"丸美生物"）密集迎来了多个关键节点。 近日，丸美生物迎来了新的联席CEO——吴梦。吴梦是上海自然堂集团有限公司原副总裁，曾是 自然堂线上业务发展的关键人物。12月12日，丸美生物旗下审计监察部官方微信公众号"廉洁丸 美"发布的文章显示了该职位的变化，吴梦以丸美生物联席CEO身份参与其反腐败合规专题培训并 发言。 此前，其创始人孙怀庆之子孙云起进入董事会；业务端，该公司计划优化线上渠道、提高运营效 率；资本市场上，已登陆A股的丸美生物正推进港股上市。 丸美生物是成立于2002年的国货美妆品牌，专注于眼部护理和抗衰领域，旗下主品牌为"丸 美"和"恋火"，二者对该公司的营收贡献超99%。"弹弹弹，弹走鱼尾纹"的广告词也家喻户晓。 据了解，吴梦曾先后担任伽蓝集团（自然堂曾用名）电子商务事业部总经理、春夏品牌事业部总经 理、营销副总裁、零售总裁等职务。今年10月，有市场消息称吴梦已从自然堂离职。在自然堂供 职时，吴梦曾被行业内称为"深耕线上的大将""长期执掌电商业务的负 ...

广东丸美生物技术股份有限公司（下称"丸美生物"）密集迎来了多个关键节点。 然而，在递交港股上市申请书的前一个月，广东证监局曾指出丸美生物存在收入核算不准确等财务问题。丸美生物修正后的业绩数据显示，2025年上半年， 该公司营业收入为17.65亿元，同比增长30.55%，在国货美妆上市公司排名中列于第十位；净利润为1.74亿元，同比下滑1.2%，排名跌出前十。 近日，丸美生物迎来了新的联席CEO——吴梦。吴梦是上海自然堂集团有限公司原副总裁，曾是自然堂线上业务发展的关键人物。12月12日，丸美生物旗下 审计监察部官方微信公众号"廉洁丸美"发布的文章显示了该职位的变化，吴梦以丸美生物联席CEO身份参与其反腐败合规专题培训并发言。 2019年上市后，丸美生物曾陷入增长瓶颈，2020—2022年其营收规模维持在17亿元，净利润连续三年下滑。2023年，丸美生物营收突破22亿元，2024年继续 上升至29亿元，净利润增速保持在28%—34%。值得注意的是，2025年上半年业绩数据修正之后，丸美生物的净利润在最近三年首次下滑。 此前，其创始人孙怀庆之子孙云起进入董事会；业务端，该公司计划优化线上渠道、提高运营效率；资本市 ...

Core Insights - The custom suit market experiences seasonal demand fluctuations, with peak seasons around wedding and job-hunting periods, while summer months see a decline in foot traffic [2][3] - Despite seasonal challenges, businesses can leverage consumer insights and targeted marketing strategies to maintain growth during off-peak periods [5][6] Market Dynamics - Custom suits are characterized by high average transaction values and lengthy production cycles, typically taking 15-20 days from fabric selection to final delivery [3][5] - The traditional off-peak season coincides with major promotional events like "520" and "618," presenting opportunities for businesses to encourage early purchases through strategic marketing [6][12] Consumer Behavior - Consumers face time costs due to the multiple visits required for custom suits, but this also presents conversion opportunities for businesses during off-peak times [5][9] - Understanding the specific needs of different consumer segments, such as grooms or their families, is crucial for tailoring marketing strategies [9][11] Marketing Strategies - Successful brands, like VinaTi, have utilized online platforms to preemptively capture consumer demand and alleviate seasonal pressures through targeted promotions [8][15] - By employing data-driven strategies and content marketing, brands can effectively engage potential customers and convert vague needs into clear purchasing decisions [19][20] Operational Insights - The integration of online channels allows custom suit brands to reach a broader audience beyond traditional geographic limitations, enhancing customer acquisition [17] - Brands should focus on continuous engagement with consumers, utilizing content to address their concerns and preferences, thereby fostering brand loyalty and long-term growth [20]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Viewpoints - The company reported a revenue of 1.496 billion yuan for the first half of 2025, a year-on-year decrease of 4.03%, with a net profit attributable to shareholders of 167 million yuan, down 9.51% year-on-year [4][5] - The second quarter of 2025 saw a revenue of 758 million yuan, a year-on-year increase of 0.87%, while the net profit attributable to shareholders was 76 million yuan, down 9.30% year-on-year [5] - The overall gross margin improved to 52.80% in Q2 2025, indicating effective product structure optimization [5] Revenue and Profit Analysis - The rehabilitation aids segment is the largest business area, generating 563 million yuan in revenue for H1 2025, a decrease of 6.41% year-on-year, primarily due to the streamlining of inefficient SKUs [5] - The medical care product segment achieved revenue of 424 million yuan, up 9.67% year-on-year, mainly due to the acquisition of Huazhou [5] - Health monitoring products generated 271 million yuan in revenue, a year-on-year increase of 12.89%, driven by strong sales of thermometers and home testing strips [5] Online and Overseas Market Performance - Online channels contributed 974 million yuan in revenue for H1 2025, a year-on-year increase of 3%, accounting for 67.28% of total operating income [6] - The company has implemented differentiated operational strategies for various e-commerce platforms, enhancing customer retention and repurchase rates through a refined membership system [6] - The overseas business performed exceptionally well, with revenue exceeding 100 million yuan, a year-on-year growth of over 200% [6] Strategic Acquisitions - In January 2025, the company completed the acquisition of Shanghai Huazhou, a leading domestic pressure-sensitive adhesive manufacturer, which will enhance its product line and support overseas market expansion [8] - In June 2025, the company acquired a controlling stake in Ximan Medical Systems, a well-known medical instrument retailer in Hong Kong, facilitating entry into the Hong Kong market and resource integration [8] Financial Forecast - Revenue projections for 2025-2027 are 3.58 billion yuan, 4.33 billion yuan, and 5.24 billion yuan, with growth rates of 20.0%, 21.0%, and 20.8% respectively [9] - Net profit attributable to shareholders is expected to reach 414 million yuan, 504 million yuan, and 613 million yuan for the same period, with growth rates of 32.7%, 21.8%, and 21.7% respectively [9] - The estimated EPS for 2025-2027 is 1.98 yuan, 2.41 yuan, and 2.93 yuan, corresponding to P/E ratios of 20x, 17x, and 14x [9]